Cargando…
Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial
BACKGROUND: Authors of recent meta-analyses have reported that prolonged glucocorticoid treatment is associated with significant improvements in patients with severe pneumonia or acute respiratory distress syndrome (ARDS) of multifactorial etiology. A prospective randomized trial limited to patients...
Autores principales: | Tongyoo, Surat, Permpikul, Chairat, Mongkolpun, Wasineenart, Vattanavanit, Veerapong, Udompanturak, Suthipol, Kocak, Mehmet, Meduri, G. Umberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065699/ https://www.ncbi.nlm.nih.gov/pubmed/27741949 http://dx.doi.org/10.1186/s13054-016-1511-2 |
Ejemplares similares
-
Hydrocortisone in treatment of severe sepsis and septic shock with acute respiratory distress syndrome: a randomised controlled trial
por: Tongyoo, S, et al.
Publicado: (2015) -
High-flow nasal oxygen cannula vs. noninvasive mechanical ventilation to prevent reintubation in sepsis: a randomized controlled trial
por: Tongyoo, Surat, et al.
Publicado: (2021) -
Author reply in response to a letter on “High-flow nasal oxygen cannula vs. noninvasive mechanical ventilation to prevent reintubation in sepsis: a randomized controlled trial”
por: Tongyoo, Surat, et al.
Publicado: (2021) -
Reply to El Bèze et al. and to Tung and Crowley
por: Permpikul, Chairat, et al.
Publicado: (2019) -
Serum potassium levels and outcomes in critically ill patients in the medical intensive care unit
por: Tongyoo, Surat, et al.
Publicado: (2018)